CDC Addresses Swine Flu Pandemic Threat and Need to Manufacture New Vaccine; President Obama Stresses Importance of Scientific Community

New Vaccine Technologies Needed for Pandemic; Researchers Studying Antigen-Free
Pandemic Flu Prophylaxis

Expert Commentary Available

--(Business Wire)--

WHAT: The acting director
of the CDC stated
that the
organization
believes none of the
existing
vaccinations are
effective for the
current strain of
swine flu and the
possibility of a
pandemic. In a
public statement,
President Obama
reiterated the
importance of the
scientific and
medical community in
addressing this type
of public health
challenge.

Responding quickly
to a pandemic
situation is a
challenge for most
vaccine
manufacturers whose
treatments rely on
identifying and
replicating a strain
of the virus for
vaccine creation;
antigen creation is
required and
frequently takes six
months. This time
-intensive
development and
manufacturing
process is extremely
limiting. If a
pandemic occurs in
the United States,
it is highly
unlikely that a
traditional vaccine
manufacturer will be
able to produce an
effective vaccine in
sufficient mass
volume rapidly
enough to prevent
catastrophe.

An antigen-free
pandemic flu
prophylaxis would
bypass major
drawbacks that would
severely limit the
usefulness of
conventional
vaccines in the
event of a pandemic.
According to
NanoBio, a
biopharmaceutical
company focused on
developing and
commercializing
intranasal vaccines,
up to 100 million
doses of an antigen
-free pandemic flu
prophylaxis could be
produced in one week
as an emergency
response.

WHO: Dr. James Baker,
Chief of Allergy and
Immunology at the
University of
Michigan, and
founder & CEO of
NanoBio Corp., a
biopharmaceutical
company developing
an antigen-sparing
influenza vaccine
and antigen-free
pandemic flu
prophylaxis based on
its nanoemulsion
technology platform,
is available for
comment.

Schwartz Communications
Stacey Holifield/Laura Coluci
781-684-0770
nanobio@schwartz-pr.com

Copyright Business Wire 2009